Add Formweb to your mobile device
Search results for:
levothyroxine
levothyroxine
Brand names: Levothyroxine Sodium
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 100 mcg (0.1 mg) | Restricted | ||||||||||
| TABLET, ORAL | 25 mcg (0.025 mg); 50 mcg (0.05 mg); 75 mcg (0.075 mg); 88 mcg (0.088 mg); 100 mcg (0.1 mg); 112 mcg (0.112 mg); 125 mcg (0.125 mg); 137 mcg (0.137 mg); 150 mcg (0.15 mg); 175 mcg (0.175 mg); 200 mcg (0.2 mg) |
Last updated: Nov. 30, 2021
- Black Box Warning: Treatment of obesity or weight loss
- Restricted: levothyroxine IV (Synthroid) is restricted to patients with myxedema coma, LOPA patients, pediatrics, or if a patient is NPO for a prolonged period
IV Levothyroxine should be reserved for myxedema patients, LOPA patients, pediatrics, or if a patient is NPO for a prolonged period. If IV Levothyroxine is indicated, please confirm correct dosing conversion by verifying patient's home dose (the IV dose should 50% of the oral dose).